Scandinavian ChemoTech AB Class B Financial Overview
Scandinavian ChemoTech AB Class B's market cap is currently kr111.82M. The company's EPS TTM is kr-0.054; its P/E ratio is -12.85; Scandinavian ChemoTech AB Class B is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.